Biolife Sciences Stock Market Value

BLFE Stock  USD 0.0001  0.00  0.00%   
BioLife Sciences' market value is the price at which a share of BioLife Sciences trades on a public exchange. It measures the collective expectations of BioLife Sciences investors about its performance. BioLife Sciences is trading at 1.0E-4 as of the 23rd of November 2024, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of BioLife Sciences and determine expected loss or profit from investing in BioLife Sciences over a given investment horizon. Check out BioLife Sciences Correlation, BioLife Sciences Volatility and BioLife Sciences Alpha and Beta module to complement your research on BioLife Sciences.
Symbol

Please note, there is a significant difference between BioLife Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioLife Sciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Sciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Sciences.
0.00
10/24/2024
No Change 0.00  0.0 
In 31 days
11/23/2024
0.00
If you would invest  0.00  in BioLife Sciences on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding BioLife Sciences or generate 0.0% return on investment in BioLife Sciences over 30 days. BioLife Sciences is related to or competes with GlucoTrack, Sharps Technology, Predictive Oncology, Bionano Genomics, Meihua International, Nexgel, and Pro Dex. Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature scr... More

BioLife Sciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Sciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Sciences upside and downside potential and time the market with a certain degree of confidence.

BioLife Sciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Sciences' standard deviation. In reality, there are many statistical measures that can use BioLife Sciences historical prices to predict the future BioLife Sciences' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BioLife Sciences. Your research has to be compared to or analyzed against BioLife Sciences' peers to derive any actionable benefits. When done correctly, BioLife Sciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BioLife Sciences.

BioLife Sciences Backtested Returns

We have found three technical indicators for BioLife Sciences, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioLife Sciences are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

BioLife Sciences has no correlation between past and present. Overlapping area represents the amount of predictability between BioLife Sciences time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Sciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current BioLife Sciences price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

BioLife Sciences lagged returns against current returns

Autocorrelation, which is BioLife Sciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLife Sciences' pink sheet expected returns. We can calculate the autocorrelation of BioLife Sciences returns to help us make a trade decision. For example, suppose you find that BioLife Sciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

BioLife Sciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLife Sciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLife Sciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLife Sciences pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

BioLife Sciences Lagged Returns

When evaluating BioLife Sciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLife Sciences pink sheet have on its future price. BioLife Sciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLife Sciences autocorrelation shows the relationship between BioLife Sciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in BioLife Sciences.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in BioLife Pink Sheet

BioLife Sciences financial ratios help investors to determine whether BioLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLife with respect to the benefits of owning BioLife Sciences security.